DiabetesHeadlines.com - Your source for the latest diabetes news

Diabetes is a disease in which the body does not produce or properly use insulin. Insulin is a hormone that is needed to convert sugar, starches, and other food into energy needed for daily life. It is estimated that diabetes affects more than 150 million people worldwide and is estimated to reach a staggering 300 million by the year 2025.

Visit DiabetesHeadlines.com often to stay up to date on the latest diabetes news!

Latest Diabetes News Headlines

In a major breakthrough for type 2 diabetes patients, San Diego's Amylin Pharmaceuticals won government approval Friday for Bydureon, a drug that can be injected once a week, compared with the daily or twice-daily drugs currently on the market.

Amylin Pharmaceuticals Inc. and Alkermes Plc succeeded in their third attempt to gain U.S. clearance for Bydureon, a once-weekly version of Amylin's diabetes shot.

WASHINGTON (Reuters) - Amylin Pharmaceuticals Inc won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product. After two delays, the Food and Drug Administration approved once-weekly injectable Bydureon for treating adults with Type 2 diabetes, which is linked to poor diet and lack of exercise. Bydureon is a longer-acting form of ...

Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old diabetes medicine, Byetta.

WASHINGTON (Reuters) - Amylin Pharmaceuticals won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product. After two delays, the Food and Drug Administration approved once-weekly injectable Bydureon for treating adults with Type 2 diabetes, the kind linked to poor diet and lack of exercise. Bydureon is a longer-acting form of Amylin ...

Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old product, Byetta.

Federal health regulators have approved Amylin Pharmaceutical's long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's current offering, Byetta.

SAN DIEGO (TheStreet) -- Amylin Pharmaceuticals received U.S. approval Friday for its diabetes drug Bydureon, setting the stage for a commercial battle against an established rival drug from Novo Nordisk. Bydureon's U.S. approval comes on its third attempt. The U.S. Food and Drug Administration rejected the diabetes drug last in October 2010, asking Amylin to conduct an additional study to ...

Updates with stock prices, company comment. SAN DIEGO (TheStreet) -- Amylin Pharmaceuticals received U.S. approval Friday for its diabetes drug Bydureon, setting the stage for a commercial battle against an established rival drug from Novo Nordisk. Bydureon's U.S. approval comes on its third attempt. The U.S. Food and Drug Administration rejected the diabetes drug last in October 2010, asking ...

Washington, Jan 27 (ANI): A new study has found that having diabetes may cause women to experience a greater degree of hearing loss as they age, especially if the metabolic disorder is not well controlled with medication.

Title: Lifestyle Counseling Helps Diabetes Patients Control Blood Sugar Category: Health News Created: 1/25/2012 6:05:00 PM Last Editorial Review: 1/26/2012

True or false: Many people with diabetes are too lazy to manage it properly. The answer is false, according to Dr. Paul Rosman, endocrinologist and past president of the American Diabetes Association's Ohio Chapter, this is not true.

Celebrity Southern cooking chef Paula Deen's announcement that she has Type 2 diabetes puts her in what's becoming a sizable chunk of the American population - especially in this part of the country.

We've gotten sadly accustomed by now to warnings about obesity and its effect on health: joint damage, heart disease, stroke, diabetes and its complications such as blindness and amputation. We almost take for granted that as obesity increases worldwide, diabetes will also, and it is.

Jan. 26, 2012 - Having diabetes may cause women to experience a greater degree of hearing loss as they age, especially if the metabolic disorder is not well controlled with medication, according to a new study from Henry Ford Hospital in Detroit.

( Henry Ford Health System ) Having diabetes may cause women to experience a greater degree of hearing loss as they age, especially if the metabolic disorder is not well controlled with medication, according to a new study from Henry Ford Hospital in Detroit. Women between the ages of 60 and 75 with well-controlled diabetes had better hearing than women with poorly controlled diabetes, with ...

Having diabetes may cause women to experience a greater degree of hearing loss as they age, especially if the metabolic disorder is not well controlled with medication, according to a new study from Henry Ford Hospital in Detroit. Women between the ages of 60 and 75 with well-controlled diabetes had better hearing than women with poorly controlled diabetes, with similar hearing levels to those ...

NEW YORK, Jan. 26, 2012 /PRNewswire/ --The National Basketball Association (NBA), the Women's National Basketball Association (WNBA) and the NBA Development League (NBA D-League), in collaboration with ...